TNNT2 and chronic kidney disease: Indeed, a systemic review reported that in patients with end-stage renal disease on hemodialysis or peritoneal dialysis, elevations in hs-cTnI were only reported in 3–67.4%, but up to 39–98% for hs-cTnT [12].